Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr₹-36 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹1,705 Cr
Mar2024₹8.68 Cr
Mar2023₹48 Cr
Mar2022₹16 Cr
Mar2021₹-36 Cr

How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹1,705 Cr
19,538.48
Mar2024 ₹8.68 Cr
-81.74
Mar2023 ₹48 Cr
191.02
Mar2022 ₹16 Cr
Positive
Mar2021 ₹-36 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹107,691.3 Cr 1.7% 5.8% 6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 0.7% 0.4% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -1.7% 2% 16.7% Stock Analytics
CIPLA ₹126,308.0 Cr -0.9% 5.3% -3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr -0.1% 0.6% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 4.1% 7.6% -3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.7%

5.8%

6.8%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses